Nabriva Therapeutics AG ADR buy melinda
Start price
19.09.17
/
50%
?9.37
Target price
19.10.17
€11.73
Performance (%)
-36.18%
End price
19.10.17
€5.98
Summary
This prediction ended on 19.10.17 with a price of €5.98. Massive losses of -36.18% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Nabriva Therapeutics AG ADR | - | - | - | - |
iShares Core DAX® | -1.226% | 2.804% | 14.933% | 16.561% |
iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% | 54.743% |
iShares Nikkei 225® | -1.132% | -2.218% | 5.361% | 4.560% |
iShares S&P 500 | -0.980% | 1.883% | 22.727% | 45.760% |
Comments by melinda for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
Nabriva
DUBLIN - Die Aktien der Nabriva Therapeutics boomen heute Morgen , nachdem das Unternehmen experimentelle Antibiotikum für die in der Gemeinschaft (CABP) erworben bakterielle Pneumonie Behandlung hat die Bewertungskriterien erfüllt in einer Schlüsselphase III - Studie.
(Vom Mitglied beendet)
Stopped prediction by melinda for Nabriva Therapeutics AG ADR
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?2.54
14.03.19
14.03.19
€4.51
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?5.99
19.10.17
19.10.17
€7.67
20.02.18
20.02.18
-17.17%
20.02.18
20.02.18
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?6.64
19.10.17
19.10.17
€8.50
20.02.18
20.02.18
-17.17%
20.02.18
20.02.18
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?8.75
11.05.17
11.05.17
€10.37
17.05.17
17.05.17
4.59%
17.05.17
17.05.17